A detailed history of Almanack Investment Partners, Llc. transactions in Johnson & Johnson stock. As of the latest transaction made, Almanack Investment Partners, Llc. holds 6,430 shares of JNJ stock, worth $935,436. This represents 0.18% of its overall portfolio holdings.

Number of Shares
6,430
Previous 6,350 1.26%
Holding current value
$935,436
Previous $995,000 2.21%
% of portfolio
0.18%
Previous 0.14%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

BUY
$155.22 - $162.74 $12,417 - $13,019
80 Added 1.26%
6,430 $1.02 Million
Q4 2023

Feb 07, 2024

SELL
$145.6 - $158.88 $57,657 - $62,916
-396 Reduced 5.87%
6,350 $995,000
Q3 2023

Oct 05, 2023

SELL
$155.75 - $174.48 $193,130 - $216,355
-1,240 Reduced 15.53%
6,746 $1.05 Million
Q2 2023

Aug 07, 2023

SELL
$154.35 - $166.11 $6,637 - $7,142
-43 Reduced 0.54%
7,986 $1.32 Million
Q1 2023

May 08, 2023

BUY
$151.05 - $180.26 $475,052 - $566,917
3,145 Added 64.39%
8,029 $1.24 Million
Q4 2022

Feb 08, 2023

SELL
$160.2 - $179.79 $1.04 Million - $1.17 Million
-6,492 Reduced 57.07%
4,884 $862,000
Q3 2022

Nov 14, 2022

BUY
$161.33 - $179.52 $38,396 - $42,725
238 Added 2.14%
11,376 $1.86 Million
Q2 2022

Aug 12, 2022

SELL
$168.19 - $186.01 $202,837 - $224,328
-1,206 Reduced 9.77%
11,138 $1.98 Million
Q1 2022

May 13, 2022

SELL
$158.14 - $179.59 $99,311 - $112,782
-628 Reduced 4.84%
12,344 $2.19 Million
Q4 2021

Feb 11, 2022

SELL
$155.93 - $173.01 $46,467 - $51,556
-298 Reduced 2.25%
12,972 $2.22 Million
Q3 2021

Nov 04, 2021

BUY
$161.5 - $179.47 $181,203 - $201,365
1,122 Added 9.24%
13,270 $2.14 Million
Q2 2021

Aug 04, 2021

SELL
$159.48 - $171.07 $173,673 - $186,295
-1,089 Reduced 8.23%
12,148 $2 Million
Q1 2021

May 11, 2021

BUY
$153.07 - $170.48 $103,934 - $115,755
679 Added 5.41%
13,237 $2.18 Million
Q4 2020

Feb 03, 2021

BUY
$137.11 - $157.38 $220,061 - $252,594
1,605 Added 14.65%
12,558 $1.98 Million
Q3 2020

Nov 12, 2020

BUY
$140.38 - $153.83 $232,469 - $254,742
1,656 Added 17.81%
10,953 $1.62 Million
Q2 2020

Aug 10, 2020

BUY
$128.81 - $155.51 $328,207 - $396,239
2,548 Added 37.75%
9,297 $1.31 Million
Q1 2020

May 13, 2020

BUY
$111.14 - $153.99 $297,077 - $411,615
2,673 Added 65.58%
6,749 $885,000
Q4 2019

Feb 10, 2020

SELL
$127.5 - $146.44 $765 - $878
-6 Reduced 0.15%
4,076 $595,000
Q3 2019

Nov 08, 2019

SELL
$126.95 - $142.14 $8,886 - $9,949
-70 Reduced 1.69%
4,082 $528,000
Q2 2019

Jul 31, 2019

BUY
$131.15 - $144.24 $217,971 - $239,726
1,662 Added 66.75%
4,152 $0
Q1 2019

May 15, 2019

SELL
$125.72 - $139.79 $251,942 - $280,139
-2,004 Reduced 44.59%
2,490 $348,000
Q4 2018

Jan 25, 2019

SELL
$122.84 - $147.84 $8,967 - $10,792
-73 Reduced 1.6%
4,494 $580,000
Q3 2018

Nov 13, 2018

BUY
$121.58 - $142.88 $120,364 - $141,451
990 Added 27.68%
4,567 $661,000
Q2 2018

Aug 15, 2018

SELL
$119.4 - $131.76 $41,909 - $46,247
-351 Reduced 8.94%
3,577 $434,000
Q1 2018

May 15, 2018

BUY
$125.1 - $148.14 $110,213 - $130,511
881 Added 28.91%
3,928 $503,000
Q4 2017

Feb 13, 2018

BUY
$131.22 - $143.62 $33,592 - $36,766
256 Added 9.17%
3,047 $426,000
Q3 2017

Nov 13, 2017

BUY
$129.47 - $135.38 $361,350 - $377,845
2,791
2,791 $363,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $380B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Almanack Investment Partners, Llc. Portfolio

Follow Almanack Investment Partners, Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Almanack Investment Partners, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Almanack Investment Partners, Llc. with notifications on news.